<p><strong>Gapping down</strong><br /><u>In reaction to disappointing earnings/guidance</u>: NAVR -7.1% (light volume), CRL -5.7%.</p><p><u>Other news:</u> MOS -1.9% (to appeal preliminary injunction on mine extension), V -1.5% (under pressure following reports out over the weekend that AT&T, Verizon, and T-Mobile are planning phone payment system), MET -1.1% (announces plan to offer 75 mln shares of common stock).</p><p><u>Analyst comments</u>: ARNA -3.8% (downgraded to Neutral from Overweight at JP Morgan).</p><p><strong>Gapping up</strong><br /><u>In reaction to strong earnings/guidance</u>: HBC +5.3%, OSK +4.7%, HUM +4.3%, IBN +3.1%, MNKD +1.4% (light volume).</p><p><u>Select financial related names showing strength</u>: LYG +5.3%, NBG +5.2%, HBC +5.3%, DFS +4.0%,ING +4.0%, BCS +3.9%, FIG +3.1%, STD +3.0%, IRE +2.9%, BAC +1.9%, CS +1.8%, DB +1.7%, UBS +1.7%, HBAN +1.7%, RF +1.6%, C +1.5%.</p><p><u>Select metals/mining stocks trading higher:</u> RTP +3.6%, BBL +3.5%, MT +3.3%, BHP +2.7%, VALE +2.5%, TCK +2.4%.</p><p><u>Select oil/gas related names showing strength</u>: ATPG +4.8%, KWK +4.5%, REP +3.0%, RIG +3.0%, STO +2.7%, SWN +2.7%, TOT +2.7%, HAL +2.4%, RDS.A +2.3%, XOM +1.5%, E +1.3%, BP +1.4% (trading higher on reports that the co will attempt to permanently cap the oil well this week), .</p><p><u>Select European drug names trading higher</u>: NVS +1.5%, AZN +1.4%, .</p><p><u>Select shippers ticking higher in early trade</u>: DRYS +6.9%, FRO +3.2%.</p><p><u>Other news</u>: GERN +5.5% (continued momentum), TEVA +2.4% (announces agreement with Competition Bureau of Canada regarding proposed merger with Ratiopharm), PMI +1.9% (sells investment in FGIC Corp; terms not disclosed), PURE +1.5% (PURE Bioscience's Bioscience's SDC antimicrobial effective against T. mentagrophytes in preclinical tests), .</p><p><u>Analyst comments:</u> BYD +3.7% (upgraded to Hold from Underperform at Jefferies),</p>